Giorgia Giussani Selected Research

5- nitro- 6,7,8,9- tetrahydrobenzo(G)indole- 2,3- dione- 3- oxime (NS 102)

1/2018

Incidence of neonatal seizures, perinatal risk factors for epilepsy and mortality after neonatal seizures in the province of Parma, Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgia Giussani Research Topics

Disease

10	Epilepsy (Aura) 08/2022 - 05/2013
5	Seizures (Absence Seizure) 01/2021 - 10/2013
2	Wounds and Injuries (Trauma) 08/2022 - 05/2014
2	Epileptic Syndromes 01/2018 - 10/2013
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2022
1	COVID-19 05/2022
1	Neurologic Manifestations (Neurological Manifestations) 05/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2020
1	Asphyxia (Suffocation) 01/2020
1	Hemorrhage 01/2020
1	Pregnancy Complications 01/2020
1	Dementia (Dementias) 10/2019
1	Vomiting 01/2019
1	Headache (Headaches) 01/2019
1	Nausea 01/2019
1	Sleep Deprivation 01/2019
1	Generalized Epilepsy 04/2016
1	Drug Resistant Epilepsy 02/2016
1	Malnutrition (Nutritional Deficiencies) 12/2015
1	Growth Disorders 12/2015
1	Febrile Seizures (Febrile Seizure) 10/2013
1	Intellectual Disability (Idiocy) 10/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2011
1	Neoplasms (Cancer) 11/2011

Drug/Important Bio-Agent (IBA)

10	Anticonvulsants (Antiepileptic Drugs)IBA 08/2022 - 10/2013
2	Pharmaceutical PreparationsIBA 01/2021 - 05/2013
1	Memantine (Namenda)FDA Link 10/2019
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2019
1	5- nitro- 6,7,8,9- tetrahydrobenzo(G)indole- 2,3- dione- 3- oxime (NS 102)IBA 01/2018
1	SmokeIBA 12/2015
1	Trichloroethylene (Trichloroethene)IBA 12/2015
1	ORALIT (ORS)IBA 05/2014
1	Coffee FDA Link 11/2011

Therapy/Procedure

2	Therapeutics 10/2019 - 05/2013
1	Length of Stay 05/2022
1	Resuscitation 01/2020
1	Cholecystectomy 01/2019
1	Aftercare (After-Treatment) 10/2013